Arcus Biosciences RCUS Earnings Call Transcripts

NYSE RCUS
$18.93 +0.65 (+3.56%)
At close: Nov 9, 2026 · 4:00 PM EST
3 earnings calls on file for Arcus Biosciences, from Q4 2025 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Arcus Biosciences Q2 2026 Earnings Call

Aug 5, 2026 8,376 words · 36 min read
  • Pia EavesVice President of Investor Relations
  • Terry RosenChief Executive Officer
  • Richard MarkusChief Medical Officer
  • Juan JaenPresident
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Arcus Biosciences Earnings Call Transcripts

Calls3
LatestAug 5, 2026
SinceQ4 2025

Fiscal 2026

Fiscal 2025

All 3 Arcus Biosciences transcripts Register to get access to Arcus Biosciences’s earnings call transcripts.